Stem cell therapy for chronic heart failure: an updated appraisal

Bibliography

• Kehat I, Kenyagin-Karsenti D, Snir M, Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-14
   PubMed Web of Science ®Google Scholar
• Thomson JA, Itskovitz-Eldor J, Shapiro SS, Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-7
   PubMed Web of Science ®Google Scholar
• Tran TH, Wang X, Browne C, Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells. Stem Cells 2009;27:1869-78
   PubMed Web of Science ®Google Scholar
• Laflamme MA, Chen KY, Naumova AV, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007;25:1015-24
   PubMed Web of Science ®Google Scholar
• van Laake LW, Passier R, Monshouwer-Kloots J, Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res 2007;1:9-24
   PubMed Web of Science ®Google Scholar
• Nussbaum J, Minami E, Laflamme MA, Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J 2007;21:1345-57
   PubMed Web of Science ®Google Scholar
• Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008;100:133-58
   PubMed Web of Science ®Google Scholar
• Draper JS, Fox V. Human embryonic stem cells: multilineage differentiation and mechanisms of self-renewal. Arch Med Res 2003;34:558-64
   PubMed Web of Science ®Google Scholar
• Gupta MK, Walthall JM, Venkataraman R, Combinatorial polymer electrospun matrices promote physiologically-relevant cardiomyogenic stem cell differentiation. PLoS One 2011;6:e28935
   PubMedGoogle Scholar
• Takahashi K, Okita K, Nakagawa M, Yamanaka S. Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2007;2:3081-9
   PubMed Web of Science ®Google Scholar
• Narazaki G, Uosaki H, Teranishi M, Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008;118:498-506
   PubMed Web of Science ®Google Scholar
• Zhang J, Wilson GF, Soerens AG, Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009;104:e30-41
   PubMed Web of Science ®Google Scholar
• Yu J, Hu K, Smuga-Otto K, Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324:797-801
   PubMed Web of Science ®Google Scholar
• Nelson TJ, Martinez-Fernandez A, Yamada S, Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009;120:408-16
   PubMed Web of Science ®Google Scholar
• Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010;24:2239-63
   PubMed Web of Science ®Google Scholar
• Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010;143:508-25
   PubMed Web of Science ®Google Scholar
• Ieda M, Fu JD, Delgado-Olguin P, Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010;142:375-86
   PubMed Web of Science ®Google Scholar
• Belema Bedada F, Technau A, Ebelt H, Activation of myogenic differentiation pathways in adult bone marrow-derived stem cells. Mol Cell Biol 2005;25:9509-19
   PubMed Web of Science ®Google Scholar
• Flaherty MP, Dawn B. Noncanonical Wnt11 signaling and cardiomyogenic differentiation. Trends Cardiovasc Med 2008;18:260-8
   PubMed Web of Science ®Google Scholar
• Subramanian K, Geraerts M, Pauwelyn KA, Isolation procedure and characterization of multipotent adult progenitor cells from rat bone marrow. Methods Mol Biol 2010;636:55-78
   PubMedGoogle Scholar
• Rota M, Kajstura J, Hosoda T, Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA 2007;104:17783-8
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 2003;7(Suppl 3):86-8
   PubMedGoogle Scholar
• Orlic D, Kajstura J, Chimenti S, Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001;98:10344-9
   PubMed Web of Science ®Google Scholar
• Kajstura J, Rota M, Whang B, Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127-37
   PubMed Web of Science ®Google Scholar
• Murayama T, Tepper OM, Silver M, Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization in vivo. Exp Hematol 2002;30:967-72
   PubMed Web of Science ®Google Scholar
• Kupatt C, Horstkotte J, Vlastos GA, Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 2005;19:1576-8
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Tomita S, Nakatani T, G-CSF promotes bone marrow cells to migrate into infarcted mice heart, and differentiate into cardiomyocytes. Cell Transplant 2004;13:741-8
   PubMed Web of Science ®Google Scholar
• Yeh HI, Lai YJ, Lee YN, Differential expression of connexin43 gap junctions in cardiomyocytes isolated from canine thoracic veins. J Histochem Cytochem 2003;51:259-66
   PubMed Web of Science ®Google Scholar
• Jujo K, Ii M, Losordo DW. Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 2008;45:530-44
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Kawamoto A, Ishikawa M, Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 2006;113:1311-25
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Suyama T, Yashita T, Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J Mol Cell Cardiol 2007;43:627-35
   PubMed Web of Science ®Google Scholar
• Alhadlaq A, Mao JJ. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 2004;13:436-48
   PubMed Web of Science ®Google Scholar
• Porada CD, Zanjani ED, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther 2006;1:365-9
   PubMedGoogle Scholar
• Pittenger MF, Mackay AM, Beck SC, Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
   PubMed Web of Science ®Google Scholar
• Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000;97:3213-18
   PubMed Web of Science ®Google Scholar
• Dai W, Hale SL, Martin BJ, Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation 2005;112:214-23
   PubMed Web of Science ®Google Scholar
• Kudo M, Wang Y, Wani MA, Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 2003;35:1113-19
   PubMed Web of Science ®Google Scholar
• Silva GV, Litovsky S, Assad JA, Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-6
   PubMed Web of Science ®Google Scholar
• Hamamoto H, Gorman JH III, Ryan LP, Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg 2009;87:794-801
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Nagaya N, Kataoka M, Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-65
   PubMed Web of Science ®Google Scholar
• Rose RA, Jiang H, Wang X, Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells 2008;26:2884-92
   PubMed Web of Science ®Google Scholar
• Gojo S, Gojo N, Takeda Y, In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003;288:51-9
   PubMed Web of Science ®Google Scholar
• Breitbach M, Bostani T, Roell W, Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 2007;110:1362-9
   PubMed Web of Science ®Google Scholar
• Buckingham M, Montarras D. Skeletal muscle stem cells. Curr Opin Genet Dev 2008;18:330-6
   PubMedGoogle Scholar
• Arsic N, Mamaeva D, Lamb NJ, Fernandez A. Muscle-derived stem cells isolated as non-adherent population give rise to cardiac, skeletal muscle and neural lineages. Exp Cell Res 2008;314:1266-80
   Google Scholar
• Pagani FD, DerSimonian H, Zawadzka A, Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003;41:879-88
   PubMed Web of Science ®Google Scholar
• Menasche P. Skeletal myoblast transplantation for cardiac repair. Expert Rev Cardiovasc Ther 2004;2:21-8
   PubMedGoogle Scholar
• Leobon B, Garcin I, Menasche P, Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003;100:7808-11
   PubMed Web of Science ®Google Scholar
• Farahmand P, Lai TY, Weisel RD, Skeletal myoblasts preserve remote matrix architecture and global function when implanted early or late after coronary ligation into infarcted or remote myocardium. Circulation 2008;118:S130-7
   PubMed Web of Science ®Google Scholar
• Fuchs S, Satler LF, Kornowski R, Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol 2003;41:1721-4
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R, Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294-302
   PubMed Web of Science ®Google Scholar
• Silva GV, Perin EC, Dohmann HF, Catheter-based transendocardial delivery of autologous bone-marrow-derived mononuclear cells in patients listed for heart transplantation. Tex Heart Inst J 2004;31:214-19
   PubMed Web of Science ®Google Scholar
• Kuethe F, Richartz BM, Kasper C, Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol 2005;100:485-91
   PubMed Web of Science ®Google Scholar
• Strauer BE, Brehm M, Zeus T, Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study. J Am Coll Cardiol 2005;46:1651-8
   PubMed Web of Science ®Google Scholar
• Hendrikx M, Hensen K, Clijsters C, Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114:I101-7
   Web of Science ®Google Scholar
• Stamm C, Kleine HD, Choi YH, Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 2007;133:717-25
   PubMed Web of Science ®Google Scholar
• Assmus B, Honold J, Schachinger V, Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006;355:1222-32
   PubMed Web of Science ®Google Scholar
• Losordo DW, Schatz RA, White CJ, Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 2007;115:3165-72
   PubMed Web of Science ®Google Scholar
• van Ramshorst J, Bax JJ, Beeres SL, Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA 2009;301:1997-2004
   PubMed Web of Science ®Google Scholar
• Menasche P, Alfieri O, Janssens S, The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008;117:1189-200
   PubMed Web of Science ®Google Scholar
• Trachtenberg B, Velazquez DL, Williams AR, Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011;161:487-93
   PubMed Web of Science ®Google Scholar
• Mazo M, Arana M, Pelacho B, Prosper F. Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap. Stem Cells Int 2012;2012:175979
   PubMed Web of Science ®Google Scholar
• Jahangir E, Fazio S, Sampson UK. Incident diabetes and statins: the blemish of an undisputed heavy weight champion? Br J Clin Pharmacol 2012; [Epub ahead of print]
   Web of Science ®Google Scholar
• Kupatt C, Hinkel R, Lamparter M, Retroinfusion of embryonic endothelial progenitor cells attenuates ischemia-reperfusion injury in pigs: role of phosphatidylinositol 3-kinase/AKT kinase. Circulation 2005;112:I117-22
   PubMed Web of Science ®Google Scholar
• Finlay MC, Hunter RJ, Baker V, A randomised comparison of Cartomerge vs. NavX fusion in the catheter ablation of atrial fibrillation: the CAVERN Trial. J Interv Card Electrophysiol 2012;33:161-9
   PubMed Web of Science ®Google Scholar
• Fermann GJ, Lindsell CJ, Storrow AB, Galectin 3 complements BNP in risk stratification in acute heart failure. Biomarkers 2012;17(8):706-13
   PubMed Web of Science ®Google Scholar
• Collins SP, Lindsell CJ, Yealy DM, A comparison of criterion standard methods to diagnose acute heart failure. Congest Heart Fail 2012;18:262-71
   PubMedGoogle Scholar
• Roden DM, Xu H, Denny JC, Wilke RA. Electronic medical records as a tool in clinical pharmacology: opportunities and challenges. Clin Pharmacol Ther 2012;91:1083-6
   PubMed Web of Science ®Google Scholar
• Monahan K, Brewster J, Wang L, Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol 2012;110:369-72
   PubMed Web of Science ®Google Scholar
• Di Salvo TG. Pulmonary hypertension and right ventricular failure in left ventricular systolic dysfunction. Curr Opin Cardiol 2012;27:262-72
   PubMed Web of Science ®Google Scholar
• Dong Y, Teoh HL, Chan BP, Changes in cerebral hemodynamic and cognitive parameters after external carotid-internal carotid bypass surgery in patients with severe steno-occlusive disease: a pilot study. J Neurol Sci 2012;322(1-2):112-16
   PubMed Web of Science ®Google Scholar
• Tse V, Xu L, Yung YC, The temporal-spatial expression of VEGF, angiopoietins-1 and 2, and Tie-2 during tumor angiogenesis and their functional correlation with tumor neovascular architecture. Neurol Res 2003;25:729-38
   PubMed Web of Science ®Google Scholar
• Tse HF, Kwong YL, Chan JK, Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 2003;361:47-9
   PubMed Web of Science ®Google Scholar
• Kamihata H, Matsubara H, Nishiue T, Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 2001;104:1046-52
   PubMed Web of Science ®Google Scholar
• Kalka C, Masuda H, Takahashi T, Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 2000;97:3422-7
   PubMed Web of Science ®Google Scholar
• Bartsch T, Brehm M, Falke T, Rapid healing of a therapy-refractory diabetic foot after transplantation of autologous bone marrow stem cells. Med Klin (Munich) 2005;100:676-80
   PubMed Web of Science ®Google Scholar
• Klein I, Cornejo JC, Polakos NK, Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 2007;110:4077-85
   PubMed Web of Science ®Google Scholar
• Eapen M, Rubinstein P, Zhang MJ, Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007;369:1947-54
   PubMed Web of Science ®Google Scholar
• Martin CM, Meeson AP, Robertson SM, Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004;265:262-75
   PubMed Web of Science ®Google Scholar
• Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells 2006;24:3-12
   PubMed Web of Science ®Google Scholar
• Laugwitz KL, Moretti A, Lam J, Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 2005;433:647-53
   PubMed Web of Science ®Google Scholar
• Thiele J, Varus E, Wickenhauser C, Mixed chimerism of cardiomyocytes and vessels after allogeneic bone marrow and stem-cell transplantation in comparison with cardiac allografts. Transplantation 2004;77:1902-5
   PubMed Web of Science ®Google Scholar
• Rosenblatt-Velin N, Lepore MG, Cartoni C, FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes. J Clin Invest 2005;115:1724-33
   PubMed Web of Science ®Google Scholar
• Bergmann O, Bhardwaj RD, Bernard S, Evidence for cardiomyocyte renewal in humans. Science 2009;324:98-102
   PubMed Web of Science ®Google Scholar
• Maltais S, Perrault LP, Ly HQ. The bone marrow-cardiac axis: role of endothelial progenitor cells in heart failure. Eur J Cardiothorac Surg 2011;39:368-74
   PubMed Web of Science ®Google Scholar
• Quevedo HC, Hatzistergos KE, Oskouei BN, Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009;106:14022-7
   PubMed Web of Science ®Google Scholar
• Heiss C, Keymel S, Niesler U, Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-8
   PubMed Web of Science ®Google Scholar
• van Vliet P, Roccio M, Smits AM, Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy. Neth Heart J 2008;16:163-9
   PubMed Web of Science ®Google Scholar
• Smith RR, Barile L, Cho HC, Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007;115:896-908
   PubMed Web of Science ®Google Scholar
• Siu CW, Tse HF. Cardiac regeneration: messages from CADUCEUS. Lancet 2012;379:870-1
   PubMed Web of Science ®Google Scholar
• Kofidis T, Lenz A, Boublik J, Bioartificial grafts for transmural myocardial restoration: a new cardiovascular tissue culture concept. Eur J Cardiothorac Surg 2003;24:906-11
   PubMed Web of Science ®Google Scholar
• Meluzin J, Mayer J, Groch L, Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: the effect of the dose of transplanted cells on myocardial function. Am Heart J 2006;152:975; e9-915
   PubMed Web of Science ®Google Scholar
• Lee SP, Youn SW, Cho HJ, Integrin-linked kinase, a hypoxia-responsive molecule, controls postnatal vasculogenesis by recruitment of endothelial progenitor cells to ischemic tissue. Circulation 2006;114:150-9
   PubMed Web of Science ®Google Scholar
• Traverse JH, Henry TD, Vaughan DE, Rationale and design for TIME: a phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction. Am Heart J 2009;158:356-63
   PubMed Web of Science ®Google Scholar
• Cheng Z, Ou L, Zhou X, Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008;16:571-9
   PubMed Web of Science ®Google Scholar
• Wei F, Wang T, Liu J, The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Exp Cell Res 2011;317:2661-70
   PubMed Web of Science ®Google Scholar
• Christoforou N, Oskouei BN, Esteso P, Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One 2010;5:e11536
   PubMed Web of Science ®Google Scholar
• Storrow AB, Lindsell CJ, Collins SP, Standardized reporting criteria for studies evaluating suspected acute heart failure syndromes in the emergency department. J Am Coll Cardiol 2012;60:822-32
   PubMed Web of Science ®Google Scholar
• Assmus B, Fischer-Rasokat U, Honold J, Transcoronary transplantation of functionally competent BMCs is associated with a decrease in natriuretic peptide serum levels and improved survival of patients with chronic postinfarction heart failure: results of the TOPCARE-CHD Registry. Circ Res 2007;100:1234-41
   PubMed Web of Science ®Google Scholar
• van der Bogt KE, Schrepfer S, Yu J, Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation 2009;87:642-52
   PubMed Web of Science ®Google Scholar